Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia

Psychological Medicine

Volumn 28, Issue 4, 1998, Pages 957-965

  Maes, M ^a   Libbrecht, I ^b   Van Hunsel, F ^b   Lin, A H ^b   Bonaccorso, S ^b   Goossens, F ^b   De Meester, I ^b   De Clerck, L ^b   Biondi, M ^b   Scharpe, S ^b   Janca, A ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PROLYL ENDOPEPTIDASE; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; ENZYME ACTIVITY; FEMALE; FIBROMYALGIA; HUMAN; HYPERALGESIA; MALE; NOCICEPTION; ORAL DRUG ADMINISTRATION; RATING SCALE; TIME;

ANTIGENS, CD26; DEPRESSIVE DISORDER; FEMALE; FIBROMYALGIA; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SERINE ENDOPEPTIDASES;

EID: 0031825327     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291798006801     Document Type: Article

References (51)

1. Abassi, Z., Golomb, E. & Keiser, H. R. (1992). Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin. Metabolism 41, 683-685.
2. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC.
3. Barnes, K., Bourne, A., Cook, P. A., Turner, A. J. & Kenny, A. J. (1991). Membrane peptidases in the peripheral nervous system of the pig: their localization by immuno histochemistry at light and electron microscopic levels. Neuroscience 44, 245-261.
4. Barton, R. W., Prendergast, J. & Kennedy, C. A. (1990). Binding of the T cell activation monoclonal antibody TA1 to dipeptidyl peptidase IV. Journal of Leukocyte Biology 48, 291-296.
5. Bathon, J. M., Proud, D., Mizutani, S. & Ward, P.E. (1992). Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. Journal of Clinical Investigation 9, 981-991.
6. Bhoola, K. D., Figueroa, C. D. & Worthy, K. (1992). Bioregulation of kinins: kallikreins, kilinogens, and kininases. Pharmacological Reviews 44, 1-80.
7. Blumer, D. & Heilbronn, M. (1987). Depression and chronic pain. In Presentations of Depression (ed. O. G. Cameron), pp. 215-235. John Wiley: New York.
8. De Meester, I., Mertens, A. V., De Clerck, L. S., Scharpé, S., Bridts, C. H. & Stevens, W. J. (1993). Correlations between dipeptidyl peptidase IV and disease activity of rheumatoid arthritis (RA). Journal of Allergy and Clinical Immunology 91, 228-232.
9. Dray, A. & Perkins, M. (1993). Bradykinin and inflammatory pain. Trends in Neurosciences 16, 99-104.
10. Duke-Cohan, J. S., Morimoto, C., Rocker, J. A. & Schlossman, S. F. (1995). A novel form of dipeptidylpeptidase IV found in human serum: isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). Journal of Biological Chemistry 270, 14107-14114.
11. Goldenberg, D., Mayskiy, M., Mossey, C., Ruthazer, R. & Schmid, C. (1996). A randomized, double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis and Rheumatism 39, 1852-1859.
12. Goossens, F., De Meester, I., Vanhoof, G. & Scharpé, S. (1992). A sensitive method for the assay of serum prolyl endopeptidase. European Journal of Clinical Chemistry and Clinical Biochemistry 30, 235-238.
13. Goossens, F., De Meester, I., Vanhoof, G. & Scharpe, S. (1996). Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. European Journal of Clinical Chemistry and Clinical Biochemistry 34, 17-22.
14. Gruber, A. J., Hudson, J. I. & Pope, H. G. (1996). The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatric Clinics of North America 19, 351-369.
15. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-61.
16. Hawley, D. J. & Wolfe, F. (1993). Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6153 patients with rheumatic disease. Journal of Rheumatology 20, 2025-2031.
17. Hopsu-Havu, V K. & Glenner, G. G. (1966). A new dipeptide naphthylamidase hydrolyzing glycyl-propyl-β-naphthylamide. Hisrochemistry 7, 197-201.
18. Hudson, J. I., Hudson, M. S., Pliner, L. F., Goldenberg, D. L., Pope, H. G. Jr. (1985). Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. American Journal of Psychiatry 142, 441-446.
19. Hudson, J. I., Goldenberg, D. L., Pope, H. G., Keck, P. E. & Schlesinger, L. (1992). Comorbidity of fibromyalgia with medical and psychiatric disorders. American Journal of Medicine 92, 363-367.
20. Kato, T., Nagatsu, T., Fukasawa, K., Harada, M., Nagatsu, I. & Sakakibara, S. (1978). Successive cleavage of N-terminal Arg-Pro and Lys-Pro from substance P but no release of Arg-Pro from bradykinin, by X-Pro dipeptidyl-aminopeptidase. Biochimica et Biophysica Acta 525, 417-422.
21. Kato, T., Nakano, T., Kojima, K., Nagatsu, T. & Sakakibara, S. (1980a). Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. Journal of Neurochemistry 35, 527-535.
22. Kato, T., Okada, M. & Nagatsu, T. (1980b). Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Molecular and Cellular Biochemistry 32, 117-121.
23. Krag, N. J., Norregaard, J., Larsen, J. K. & Danneskiold-Samsoe, B. (1994). A blinded controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatrica Scandinavica 89, 370-375.
24. Lotz, M., Vaughan, J. H. & Carson, D. A. (1988). Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241, 128-1221.
25. Maes, M., De Meester, I., Vanhoof, G., Scharpé, S., Bosnians, E., Vandervorst, C., Verkerk, R., Minner, B., Suy, E. & Raus, J. (1991). Decreased serum dipeptidyl peptidase IV activity in major depression. Biological Psychiatry 30, 577-586.
26. Maes, M., Goossens, F., Scharpe, S., Meltzer, H. Y., D'Hondt, P. & Cosyns, P. (1994a). Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biological Psychiatry 35, 545-552.
27. Maes, M., Scharpé, S., De Meester, I., Goossens, P., Wauters, A., Neels, H., Verkerk, R., De Meyer, F., D'Hondt, P., Peeters, D., Schotte, C. & Cosyns, P. (1994b). Components of biological variation in plasma prolyl endopeptidase and dipeptidyl peptidase activity in healthy man. Clinical Chemistry 40, 1686-1691.
28. Maes, M., Scharpe, S., Meltzer, H. Y. & Calabrese, J. (1995). Plasma prolyl endopeptidase enzyme activity in major depression, schizophrenia and mania: effects of antidepressive drugs, neuroleptics and valproate. Psychiatry Research 58, 217-225.
29. Maes, M., Scharpé, S., Meltzer, H. Y. & Calabrese, J. (1996). Dipeptidyl peptidase serum activity in depression, schizophrenia and mania: effects of antidepressive drugs, neuroleptics and valproate. Acta Psychiatrica Scandinavica 93, 1-8.
30. Menkes, C. J. & Renoux, M. (1994). Substance P and rheumatic diseases. Revue du Prat 44, 1569-1571.
31. Moldofsky, H. (1995). Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Advances in Neurolmmunology 5,4 39-56.
32. Moriyama, A., Nakanishi, M. & Sasaki, M. (1988). Porcine muscle endopeptidase and its endogenous substrates. Journal of Biochemistry 104, 112-117.
33. Nagatsu, T., Hino, M., Fuyamada, H., Hayakawa, T., Sakibara, S., Nakagawa, Y. & Takemoto, T. (1976). New chromogenic substrates for X-Pro dipeptidyl aminopeptidase. Anales de Biochemie 74, 466-476.
34. Pernow, B. (1983). Substance P. Pharmacological Reviews 35, 85-141.
35. Piercey, M. F., Moon, M. W., Blinn, J. R. & Dobry-Schreur, P. J. K. (1986). Analgesic activities of spinal cord substance P antagonists implicate substance P as a neurotransmitter of pain sensation. Brain Research 385, 74-85.
36. Rauner, R. A., Schmidt, J. J. & Najjar, V. A. (1976). Proline endopeptidase and exopeptidase activity in polymorphonuclear granulocytes. Molecular and Cellular Biochemistry 10, 77-80.
37. Reinhold, D., Wrenger, S., Bank, U., Buhling, F., Hoffmann, T., Neubert, K., Kraft, M., Frank, R. & Ansorge, S. (1966). CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells. Immunobiology 195, 119-128.
38. Saelid, G., Haug, J. O., Heiberg, T. & Reichelt, K. L. (1985). Peptide containing fractions in depression. Biological Psychiatry 20, 254-256.
39. Sandberg, B. E. B. & Iversen, L. L. (1982). Substance P. Journal of Medicinal Chemistry 25, 1009-1015.
40. Saria, A. (1987). The role of substance P and other neuropeptides in transmission of pain. Acta Neurochirurgica 38 (Suppl), 33-35.
41. Schon, E., Demuth, H. U., Eichmann, E., Horst, H.-J., Korner, I.-J., Kopp, J., Mattern, T., Neubert, K., Noll, F., Ulmer, A. J., Barth, A. & Ansorge, S. (1989). Dipeptidyl peptidase IV in human T lymphocytes. Scandinavian Journal of Immunology 29, 127-132.
42. Spitzer, R. L., Williams, J. B. W., Gibbon, M. S. W. & First, M. B. (1990). Structured Clinical Interview according to DSM-III-R. American Psychiatric Press: Washington, DC.
43. Tanaka, T., Duke-Cohan, J. S., Kameoka, J., Yaron, A., Lee, I., Schlossman, S. F. & Morimoto, C. (1994). Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proceedings of the National Academy of Sciences of the United States of America 91, 3082-3086.
44. Tracey, D. J. & Walker, J. S. (1995). Review: pain due to nerve damage: are inflammatory mediators involved? Inflammation Research 44, 407-411.
45. Vanhoof, G., De Meester, I., van Sande, M., Scharpe, S. & Yaron, A. (1992). Distribution of proline-specific aminopeptidases in human tissues and body fluids. European Journal of Clinical Chemistry and Clinical Biochemistry 30, 333-338.
46. Watanabe, Y., Kojima-Komatsu, T., Iwaki-Egawa, S. & Fujimoto, Y. (1993). Increased excretion of proline-containing peptides in dipeptidyl peptidase IV deficient rats. Research Communications in Chemical Pathology and Pharmacology 81, 323-330.
47. Watkins, L. R., Maier, S. F. & Goehler, L. E. (1995). Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63, 289-302.
48. Welches, W. R., Brosnihan, K. B. & Ferrario, C. M. (1993). A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sciences 52, 1461-1480.
49. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P. et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33, 160-172.
50. Yaron, A. & Naider, F. (1993). Proline-dependent structural and biological properties of peptides and proteins. Critical Reviews in Biochemistry and Molecular Biology 28, 31-81.
51. Zweig, M. H. & Campbell, G. (1993). Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 39, 561-577.